title: Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment.
authors.affiliation: Department of Urology, Sant'Andrea Hospital, Faculty of Health Sciences, Sapienza University, Via di Grottarossa 1035, 00189 Rome, Italy.
authors.forename: Cosimo
authors.initials: C
authors.lastname: De Nunzio
authors.affiliation: Department of Urology, Sant'Andrea Hospital, Faculty of Health Sciences, Sapienza University, Via di Grottarossa 1035, 00189 Rome, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Tubaro
mesh_terms: D065087:Acetylcholine Release Inhibitors / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D053685:Laser Therapy; D059411:Lower Urinary Tract Symptoms / Q000628:therapy; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000628:therapy*; D053448:Prostatism / Q000628:therapy*; D000069464:Solifenacin Succinate / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D000068581:Tadalafil / Q000627:therapeutic use; D000077409:Tamsulosin; D020728:Transurethral Resection of Prostate / Q000379:methods*; D064804:Urological Agents / Q000627:therapeutic use*
chemical_list: D065087:Acetylcholine Release Inhibitors; D004338:Drug Combinations; D058986:Phosphodiesterase 5 Inhibitors; D013449:Sulfonamides; D064804:Urological Agents; D000068581:Tadalafil; D019274:Botulinum Toxins, Type A; D000077409:Tamsulosin; D000069464:Solifenacin Succinate